This decade is the age of the biobank, says Lauren Taylor, a scientist and solutions manager in Digital Sciences at Thermo Fisher Scientific. She shares her thoughts on the importance of IoT and LIMS with DDW. Never have we seen such investment, growth and interest in the meticulous collection of… Read More
Listen to this article on the DDW Podcast: Researchers often ask whether a LIMS or an ELN is right for them. In this two-part series, Barry Bunin, PhD, CEO at Collaborative Drug Discovery, offers a guide to understanding what a LIMS is, and how it differs from other scientific… Read More
Listen to this article on the DDW Podcast: Laura Marozsan, Scientific Marketing Specialist, Thermo Fisher Scientific, outlines the benefits of automation in drug discovery. Automation plays a crucial role in modern drug discovery, enabling improvements in efficiency, standardisation, reproducibility and data integrity. An effective automated laboratory contains two main… Read More
